PT Bio Farma
Clinical trials sponsored by PT Bio Farma, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can one visit cover HPV and tetanus protection? a phase 3 trial puts the question to the test Results expected Dec 2026 (estimated)
- New TB vaccine candidate enters human testing Results expected Jul 2027 (estimated)
-
New TB vaccine candidate enters human testing
Vaccine Not yet recruitingThis study tests an experimental tuberculosis vaccine called Lipovaxin in healthy adults aged 18 to 40 in Indonesia. The vaccine is given as two shots, 28 days apart, and compared to a placebo. The main goals are to check if the vaccine is safe and whether it triggers an immune r…
Phase 1 • Sponsor: PT Bio Farma • Aim: Vaccine
Last updated Jun 27, 2026 14:00 UTC
-
Can one visit cover HPV and tetanus protection? a phase 3 trial puts the question to the test
Prevention Not yet recruitingResearchers are testing whether a quadrivalent HPV vaccine can be given at the same time as a tetanus-diphtheria booster in healthy children and adolescents aged 9 to 15 in Indonesia. The trial compares children who receive both vaccines together with those who receive the HPV va…
Phase 3 • Sponsor: PT Bio Farma • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC